ELX Ellex Medical Lasers Limited

Ellex Medical Laser Ltd. (ASX:ELX), a world leading designer and manufacturer of laser systems for the ophthalmic industry, announced that it will introduce the Integre Duo, the world's first solid-state red and green photocoagulator, today at the opening of the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting in San Francisco. The Integre Duo is the world's first red/green solid-state photocoagulator, bringing choice and versatility to ophthalmologists who treat challenging retinal conditions. The Integre Duo complements Ellex' comprehensive line of lasers for cataract, glaucoma and retina treatments. Today, two thirds of the company's revenue is derived from new products released in the past three years as a result of aggressive investment in R&D and distribution focused solely on the ophthalmic laser market. Peter Falzon, Ellex' CEO, commented, "We have followed our customers desire to integrate the clinical utility and performance of the existing ion argon-krypton lasers in a solid-state laser. The Integre Duo provides the benefits of both: simultaneous true red and green wavelength selection in a compact solid-state design." The Integre Duo has been approved for sale in Japan where the first customer units will be installed in April. Pending FDA clearance in the United States, the company expects the first customer units to arrive in the US market in July. ABOUT ELLEX Ellex Medical Lasers Ltd. (ASX:ELX) designs, manufactures and markets a complete line of lasers used by ophthalmologists to preserve vision and treat eye diseases. With more than 10,000 systems delivered to the market, Ellex has evolved since 1985 from a manufacturing company of primarily OEM products, to direct marketing of its own branded products through subsidiaries in the United States and Japan and a network of distribution partners in more than 50 countries. Ellex maintains a strong emphasis on intellectual property and research into new and better treatments to manage and treat the leading causes of blindness. For additional information about Ellex and its products, please visit www.ellex.com